Published in Semin Arthritis Rheum on June 01, 2006
Gastrointestinal tract involvement in granulomatosis with polyangiitis. Prz Gastroenterol (2016) 0.79
High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet (2012) 4.46
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet (2013) 2.87
Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody. Arthritis Rheum (2004) 2.32
Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum (2008) 2.21
Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy. Arthritis Rheum (2008) 1.78
Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum (2007) 1.78
Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) (2003) 1.75
Controversies on the use of corticosteroid therapy in children with Henoch-Schönlein purpura. Semin Arthritis Rheum (2005) 1.44
A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet (2008) 1.43
Predictors of positive temporal artery biopsy in patients with giant cell arteritis and polymyalgia rheumatica (comment on the article by Marí et al.). Eur J Intern Med (2009) 1.42
Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. J Autoimmun (2009) 1.38
HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med (2003) 1.36
High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum (2007) 1.31
Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum (2011) 1.29
Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum (2008) 1.26
Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis Rheum (2006) 1.24
Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol (2012) 1.23
Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum (2002) 1.23
A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther (2010) 1.20
Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis. J Rheumatol (2006) 1.15
Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis. Arthritis Res Ther (2006) 1.13
The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine (Baltimore) (2009) 1.11
Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain. Medicine (Baltimore) (2011) 1.10
Aplasia cutis congenita in a defined population from northwest Spain. Pediatr Dermatol (2006) 1.07
Atherosclerosis in patients with biopsy-proven giant cell arteritis. Arthritis Rheum (2007) 1.03
Austrian syndrome: report of two new cases and literature review. Int J Cardiol (2005) 1.03
Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum (2004) 1.03
A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol (2005) 1.02
Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum (2004) 1.02
Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases. Rheumatol Int (2007) 1.01
Audiovestibular manifestations in patients with ankylosing spondylitis. Medicine (Baltimore) (2011) 0.99
Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Medicine (Baltimore) (2008) 0.98
Fecal immunochemical test accuracy in familial risk colorectal cancer screening. Int J Cancer (2013) 0.92
Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura. J Rheumatol (2002) 0.92
Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR). J Rheumatol (2010) 0.90
Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci (2014) 0.89
The increased risk of ventricular diastolic dysfunction and congestive heart failure in patients with rheumatoid arthritis is independent of the duration of the disease. Semin Arthritis Rheum (2005) 0.89
Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol (2002) 0.89
Pacemaker infection due to Aspergillus: report of two cases and literature review. Clin Cardiol (2005) 0.88
Moxifloxacin-induced acute liver injury. Am J Gastroenterol (2002) 0.88
Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol (2002) 0.88
Study of six X-linked tetranucleotide microsatellites: population data from five Spanish regions. Int J Legal Med (2005) 0.88
Human leukocyte antigen-DQB1 and -DRB1 associations in patients with idiopathic sudden sensorineural hearing loss from a defined population of Northwest Spain. Acta Otolaryngol (2005) 0.87
Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schönlein purpura. J Rheumatol (2006) 0.87
Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms. Arthritis Rheum (2005) 0.86
Libman-sacks endocarditis and primary antiphospholipid syndrome. J Heart Valve Dis (2005) 0.86
Interleukin 1beta gene polymorphism association with severe renal manifestations and renal sequelae in Henoch-Schönlein purpura. J Rheumatol (2004) 0.85
[Cocaine induced acute pancreatitis]. Gastroenterol Hepatol (2009) 0.85
Audiovestibular manifestations in giant cell arteritis: a prospective study. Medicine (Baltimore) (2003) 0.83
Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout. Arthritis Care Res (Hoboken) (2010) 0.83
Systemic lupus erythematosus in northwestern Spain: a 20-year epidemiologic study. Medicine (Baltimore) (2011) 0.83
Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis. J Rheumatol (2009) 0.83
Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis. J Rheumatol (2008) 0.82
Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica. J Rheumatol (2002) 0.82
Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Semin Arthritis Rheum (2006) 0.82
Lack of association between toll-like receptor 4 gene polymorphism and Henoch-Schönlein purpura. Clin Exp Rheumatol (2010) 0.81
IL-18 gene polymorphisms in Henoch-Schönlein purpura. Clin Exp Rheumatol (2010) 0.81
Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore) (2008) 0.81
HLA-B35 association with nephritis in Henoch-Schönlein purpura. J Rheumatol (2002) 0.80
Persistent chronic inflammation contributes to the development of cancer in patients with rheumatoid arthritis from a defined population of northwestern Spain. Semin Arthritis Rheum (2007) 0.80
CXCL5 gene polymorphism association with diabetes mellitus. Mol Diagn Ther (2008) 0.80
Giant cell arteritis: a new association with benign paroxysmal positional vertigo. Laryngoscope (2004) 0.80
Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis. Arthritis Res Ther (2010) 0.79
Rheumatoid arthritis and anti-TNF-alpha therapy. Atherosclerosis (2005) 0.79
Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis. J Rheumatol (2003) 0.79
The diagnosis and management of patients with giant cell arteritis. J Rheumatol (2005) 0.78
Role of asymptomatic hyperuricemia and serum uric acid levels in the pathogenesis of subclinical atherosclerosis in psoriatic arthritis: comment on the article by Chen et al. Arthritis Rheum (2009) 0.78
Rheumatoid arthritis and accelerated atherogenesis. Circulation (2004) 0.78
Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain. J Rheumatol (2005) 0.78
Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain. J Rheumatol (2007) 0.78
Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis. J Rheumatol (2004) 0.78
Giant left atrial myxoma mimicking severe mitral valve stenosis. Int J Cardiol (2007) 0.78
MCP-1 gene haplotype association in biopsy proven giant cell arteritis. J Rheumatol (2005) 0.77
Role of the C8orf13-BLK region in biopsy-proven giant cell arteritis. Hum Immunol (2010) 0.77
Tubulointerstitial nephritis and uveitis syndrome in Southern Spain. Semin Arthritis Rheum (2002) 0.77
Contribution of HLA-DRB1 shared epitope alleles and chronic inflammation to the increased incidence of cardiovascular disease in rheumatoid arthritis: comment on the article by Farragher et al. Arthritis Rheum (2008) 0.77
Response to 'Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis'. Arthritis Res Ther (2014) 0.77
Potential role of mitral valve strands on stroke recurrence in rheumatoid arthritis. Arthritis Rheum (2003) 0.77
The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis. Semin Arthritis Rheum (2008) 0.77
Glucocorticoid-related cardiovascular and cerebrovascular events in rheumatic diseases: myth or reality? Arthritis Rheum (2007) 0.77
Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in systemic sclerosis. Otol Neurotol (2008) 0.77
C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain. J Rheumatol (2009) 0.76
Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis? J Rheumatol (2006) 0.76
Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression. J Rheumatol (2011) 0.76
Etanercept-induced hypertriglyceridemia during the treatment of recurrent aphthous stomatitis. Indian J Dermatol Venereol Leprol (2013) 0.76
Pseudoachalasia of the cardia secondary to nongastrointestinal neoplasia. Dysphagia (2007) 0.76
Subclinical atherosclerosis in patients with psoriatic arthritis. J Rheumatol (2008) 0.76
Two polymorphisms in the epithelial cell-derived neutrophil-activating peptide (ENA-78) gene. Dis Markers (2005) 0.76
Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis. Clin Exp Rheumatol (2011) 0.76
The pros and cons of intravenous immunoglobulin treatment in autoimmune nephropathy. Semin Arthritis Rheum (2004) 0.76
Lack of association between TRAF1/C5 gene polymorphisms and biopsy-proven giant cell arteritis. J Rheumatol (2009) 0.76
Raynaud's phenomenon and serotonin reuptake inhibitors. J Rheumatol (2004) 0.76
Lack of association between RETN rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients. Clin Exp Rheumatol (2011) 0.76
Lack of association between hypoxia inducible factor-1 alpha gene polymorphisms and biopsy-proven giant cell arteritis. Clin Exp Rheumatol (2010) 0.76
Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets. Ann Rheum Dis (2011) 0.76
Functional capacity in rheumatoid arthritis patients: comparison between Spanish and Brazilian sample. Rheumatol Int (2009) 0.75
Re: Autoimmunity in sudden sensorineural hearing loss...by Cadoni et al. Acta Otolaryngol (2003) 0.75
Long-term rheumatoid arthritis and endothelial dysfunction. Atherosclerosis (2004) 0.75
Polymyalgia rheumatica and biopsy-proven giant cell arteritis exhibit different HLA-DRB1* associations. J Rheumatol (2003) 0.75